Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen and nitrogen species (ROS and RNS) signaling in macrophages is a complex physiological process rather than a single molecular target. It involves the coordinated production of reactive molecules like superoxide (O2•−) and nitric oxide (NO) by enzymes such as NADPH oxidase (NOX2) and inducible nitric oxide synthase (iNOS) [1][2]. These species function as potent antimicrobial agents during the innate immune response and as secondary messengers that modulate key transcription factors like NF-κB and AP-1 [3]. Dysregulation of this signaling network is a hallmark of chronic inflammatory conditions, autoimmune diseases, and cancer, where persistent oxidative stress drives tissue injury [4]. Pharmacological strategies aimed at this pathway include the use of antioxidants, NOX inhibitors, and iNOS antagonists, though achieving specificity without compromising host immunity remains a significant therapeutic challenge [5]. (Citations: [1] Mittal M, et al. 2014, Antioxidants & Redox Signaling; [2] Bogdan C. 2001, Nature Immunology; [3] Forman HJ, Torres M. 2002, Gene; [4] Nathan C, Cunningham-Bussel A. 2013, Nature Reviews Immunology; [5] Lambeth JD. 2004, Nature Reviews Immunology).
Inhibition of ROS/RNS-generating enzymes (e.g., NOX2, iNOS), scavenging of reactive intermediates, and modulation of redox-sensitive transcription factors to restore homeostatic balance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen and nitrogen species signaling in macrophages (ROS/RNS signaling).